Narinder Pal Bhalla

Insider Reports History

Location
Chadds Ford, PA
Signature
/s/ Carole Rosenberg, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Narinder Pal Bhalla:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. Chief Medical Officer Common Stock 49,500 $367,785 $7.43 13 Feb 2026 Direct
Lexeo Therapeutics, Inc. Chief Medical Officer Stock Option (right to buy) 297,000 13 Feb 2026 Direct

Insider Reports Filed by Narinder Pal Bhalla

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXEO Lexeo Therapeutics, Inc. 13 Feb 2026 2 $0 4 Chief Medical Officer 17 Feb 2026, 16:55
LXEO Lexeo Therapeutics, Inc. 20 Jan 2026 0 $0 3 Chief Medical Officer 05 Feb 2026, 16:45